Screener
Agios Pharmaceuticals AGIO Cash Flow Statement
| Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | ||
|---|---|---|---|---|---|---|
| -$100.7M+10.1% | -$99.11M-11.0% | -$108.04M— | -$103.43M-111% | -$112.02M-16.5% | ||
| $1.35M+7.2% | $1.36M+6.7% | $1.27M-7.4% | $1.37M+2.2% | $1.26M-21.0% | ||
| $15.94M+8.5% | $15.54M+36.8% | $14.12M+29.5% | $12.38M+11.1% | $14.69M+27.0% | ||
| -$57.31M+25.7% | -$118.92M-6.7% | -$96.21M+27.8% | -$88.15M-4.7% | -$77.12M-6.2% | ||
| $1.21M+38.5% | $769K+0.4% | $1.12M+15.8% | $1.56M+271% | $875K+454% | ||
| $40.21M-49.1% | $141.31M+25.5% | $90.08M— | $95.56M-61.9% | $78.97M+112% | ||
| $3.15M+4,745% | $2.08M+28.4% | $2.56M-47.2% | $4.44M+68.2% | $65K-94.1% | ||
| —— | $24.47M+801% | —— | $11.84M-93.0% | $1.91M+106% | ||
| -$58.52M+25.0% | -$119.69M-6.6% | -$97.33M+27.4% | -$89.71M-6.0% | -$78M-7.2% |
FAQ
- How much cash does Agios Pharmaceuticals generate?
- Agios Pharmaceuticals (AGIO) generated -$360.6M in operating cash flow over the trailing twelve months.
- What is Agios Pharmaceuticals's free cash flow?
- After $4.7M of capital expenditures, Agios Pharmaceuticals's free cash flow was -$365.3M over the trailing twelve months, up 10.7% year over year.
- Where does Agios Pharmaceuticals's cash flow data come from?
- Every line is extracted from Agios Pharmaceuticals's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
